• The document is an intimation regarding the availability of an audio recording for the company's Earnings Call.
  • The event type is an Earnings Call to discuss operational and financial performance.
  • The call was held on August 14, 2026.
  • The purpose of the event was the discussion of the company's operational and financial performance for the quarter ended June 30, 2026 (Q1 FY27).
  • The audio recording is available on the Company's website at: https://www.supriyalifescience.com/ir-financial.php.
  • The letter is signed by Prachi Sathe, Company Secretary & Compliance Officer.

Additional Notes Section

  • This is a follow-up to previous letters dated August 10, 2026, and August 13, 2026.
  • The document itself is a compliance filing sent to the BSE and NSE and contains no financial data or performance figures.
  • The document does not specify if unpublished price sensitive information (UPSI) was or was not shared during the call.
  • No management participants, presentation decks, or transcripts are mentioned as being available in this specific filing.